Hijazi, Z., Oldgren, J., Lindback, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., … Wallentin, L. (2017). A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials. In EUROPEAN HEART JOURNAL (Vol. 38, pp. 1221–1221). OXFORD UNIV PRESS.

Hijazi, Z., J. Oldgren, J. Lindback, J. H. Alexander, S. J. Connolly, J. W. Eikelboom, M. D. Ezekowitz, et al. “A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials.” In EUROPEAN HEART JOURNAL, 38:1221–1221. OXFORD UNIV PRESS, 2017.

Hijazi Z, Oldgren J, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, et al. A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2017. p. 1221–1221.

Hijazi, Z., et al. “A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials.” EUROPEAN HEART JOURNAL, vol. 38, OXFORD UNIV PRESS, 2017, pp. 1221–1221.

Hijazi Z, Oldgren J, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L. A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2017. p. 1221–1221.